The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,946.00
Bid: 2,944.00
Ask: 2,946.00
Change: 27.00 (0.92%)
Spread: 2.00 (0.068%)
Open: 2,916.00
High: 2,946.00
Low: 2,907.00
Prev. Close: 2,919.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Action Capital Markets Seminar & portfolio update

21 Mar 2024 07:00

RNS Number : 7017H
3i Group PLC
21 March 2024
 

 

21 March 2024

 

3i Group plc

Action Capital Markets Seminar and portfolio update

 

3i Group plc ("3i", or "the Group") will be holding a capital markets seminar this morning, involving presentations from the management team of Action, our largest portfolio company. The seminar will include a presentation on Action's results and strategy, as well as a separate presentation focused on Action's sustainability programme. A live webcast of the seminar will take place at 10:00 (UK time), with the sustainability session starting at 12:30 after a short break, and expected to end by 13:15. To register for the webcast, please visit https://www.3i.com/investor-relations. An on-demand webcast of the seminar will also be available by the end of the day.

 

As disclosed in our Q3 performance update, in its 2023 financial year Action generated net sales of ?11,324 million and operating EBITDA of ?1,615 million, 28% and 34% respectively higher than in 2022. Like-for-like sales growth was 16.7% and the business added 303 stores in the year. Operating leverage and good cost discipline were the main drivers behind the increased EBITDA margin of 14.3%.

 

Action has seen a strong start to 2024 across all its geographies. In the period to the end of week 11, net sales were ?2.5 billion, 21% ahead of the same period in 2023. Like-for-like sales growth in the first 11 weeks of the year (which, compared to the same period last year, had one fewer trading day) was 9.6%, with growth in transactions accounting for over 100% of the strong performance. Cash and cash equivalents as at 17 March 2024 was ?1,077 million. The business has added 32 stores in the year to date, including Action's first two stores in Portugal. Action is planning to make another dividend payment to shareholders in the last week of March. More details on Action's performance will be available in the presentation.

 

We have also recently completed our semi-annual portfolio company review meetings. The rest of the 3i portfolio continues to demonstrate overall resilience with the majority of companies showing good momentum into 2024. Our full year results will be published in May.

 

- Ends -

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

Notes to editors:

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURVURSNUOUUR
Date   Source Headline
5th Jan 20224:58 pmRNSDirector/PDMR Shareholding
4th Jan 20229:43 amRNSPortfolio Update
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSDirectorate Change
9th Dec 202110:57 amRNSBlock listing Interim Review
30th Nov 20213:53 pmRNSTotal Voting Rights
30th Nov 20213:52 pmRNSDirector/PDMR Shareholding
30th Nov 202111:53 amRNSDirector/PDMR Shareholding
11th Nov 202111:05 amRNSDirectorate Change
11th Nov 20219:52 amRNSDoc re. Half Yearly Report 2021
11th Nov 20217:02 amRNSGroup Finance Director succession
11th Nov 20217:00 amRNSResults for the six months to 30 September 2021
3rd Nov 20211:44 pmRNSHolding(s) in Company
2nd Nov 20217:30 amRNS3i portfolio company Action announces new CEO
29th Oct 20212:29 pmRNSTotal Voting Rights
29th Oct 20212:22 pmRNSDirector/PDMR Shareholding
1st Oct 202112:59 pmRNSDirector/PDMR Shareholding
1st Oct 202110:04 amRNSPortfolio Update
30th Sep 20214:16 pmRNSTotal Voting Rights
30th Sep 20214:15 pmRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSDirectorate Change
29th Sep 20212:25 pmRNSDirector/PDMR Shareholding
28th Sep 20219:27 amRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSUpdate on portfolio and Capital Markets Seminar
21st Sep 202112:27 pmRNSDirector/PDMR Shareholding
31st Aug 20214:00 pmRNSTotal Voting Rights
31st Aug 20213:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:25 amRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSFY2022 Q1 performance update
1st Jul 20213:14 pmRNSDirector/PDMR Shareholding
1st Jul 20213:07 pmRNSDirector/PDMR Shareholding
1st Jul 202111:47 amRNSResult of AGM
1st Jul 202111:42 amRNSDoc re. AGM Resolutions
1st Jul 20219:59 amRNSPortfolio Update
30th Jun 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20214:09 pmRNSTotal Voting Rights
30th Jun 20214:04 pmRNSDirector/PDMR Shareholding
29th Jun 20212:24 pmRNSDirector/PDMR Shareholding
29th Jun 20211:55 pmRNSDirector/PDMR Shareholding
10th Jun 202110:55 amRNSBlock listing Interim Review
8th Jun 20212:25 pmRNSDirector/PDMR Shareholding
4th Jun 20212:35 pmRNSDirector/PDMR Shareholding
3rd Jun 202112:12 pmRNSDirector/PDMR Shareholding
2nd Jun 20219:48 amRNSDTR 6.3.5
28th May 20215:05 pmRNSTotal Voting Rights
28th May 20215:01 pmRNSDirector/PDMR Shareholding
26th May 20213:16 pmRNSDoc re. 2021 Notice of AGM
19th May 202111:56 amRNSDoc re. 2021 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.